Skip to content
OpenCapital
Get started

ClearPoint Neuro CLPT Cash & Equivalents

Cash & Equivalents at other companies

Abbott logo
AbbottABT
$6.8B+4.1%
Boston Scientific logo
Boston ScientificBSX
$850M+146%
IAR
Integra LifeSciencesIART
$236.81M-1.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$424.2M-69.4%
Medtronic logo
MedtronicMDT
$1.95B-12.1%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$15.63M-42.4%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's cash & equivalents?
ClearPoint Neuro (CLPT) reported cash & equivalents of $36.52M in Q1 2026.
How has ClearPoint Neuro's cash & equivalents changed year-over-year?
ClearPoint Neuro's cash & equivalents increased by 194.8% year-over-year, from $12.39M to $36.52M.
What is the long-term trend for ClearPoint Neuro's cash & equivalents?
Over 5 years (2020 to 2025), ClearPoint Neuro's cash & equivalents has grown at a 18.5% compound annual growth rate (CAGR), from $20.1M to $46.97M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.